Royal Society of Chemistry, Biomaterials Science, 9(9), p. 3228-3243, 2021
DOI: 10.1039/d1bm00137j
Full text: Unavailable
Immunomodulatory nanomedicine has the potential to modulate CRC tumors with distinct associated immune cells, leading to the recruitment and activation of the immune populations, which will further, recognize tumor cells and allow its elimination.